The physiological function of drug-transporting P-glycoproteins

Seminars in Cancer Biology
A H Schinkel

Abstract

The mammalian drug-transporting or mdr1-type P-glycoproteins can extrude a range of structurally diverse, toxic xenobiotic compounds from cells. Our analysis of knockout mice lacking one or both of the mdr1-type P-glycoproteins indicates that a major function of these proteins is the protection of organisms against many of the toxic xenobiotics to which they can potentially be exposed in nature. P-glycoprotein confers protection by limiting the uptake of compounds from the gastrointestinal tract, and by stimulating excretion of compounds in the liver, kidney, and intestine. Moreover, P-glycoprotein in the blood-brain barrier and other blood-tissue barriers protects sensitive organs from exposure to toxic compounds that may have entered the bloodstream. Although we cannot exclude additional physiological functions for mdr1-type P-glycoproteins, these are not vital, since the mdr1-deficient mice are viable and fertile, and do not display obvious phenotypic abnormalities other than hypersensitivity to drugs.

Citations

Feb 13, 2001·Acta Anaesthesiologica Scandinavica·T H Fagerlund, O Braaten
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
Mar 17, 2001·British Journal of Pharmacology·K BogmanJ Drewe
May 3, 2003·Journal of Experimental Therapeutics & Oncology·Chow H Lee, Victor Ling
Jul 9, 2002·British Journal of Haematology·Rodrigo T CaladoRoberto P Falcão
Oct 8, 1999·International Journal of Urology : Official Journal of the Japanese Urological Association·S NaitoH Koga
Nov 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Linlin SuC Yan Cheng
Oct 7, 2005·Journal of Toxicology and Environmental Health. Part a·Eun Jeong Yoo, Byung Mu Lee
Dec 23, 2009·DNA and Cell Biology·Güvem Gümüş-AkayAsuman Sunguroğlu
Feb 14, 2009·Science·Sara Ricardo, Ruth Lehmann
Nov 25, 2003·Gut·C G DietrichR P J Oude Elferink
Nov 10, 2001·Annual Review of Genomics and Human Genetics·W E Evans, J A Johnson
May 20, 1999·Annual Review of Pharmacology and Toxicology·S V AmbudkarM M Gottesman
Oct 3, 2002·Annual Review of Pharmacology and Toxicology·Matthias SchwabMartin F Fromm
Jan 13, 2006·Annual Review of Pharmacology and Toxicology·P Krishnamurthy, J D Schuetz
Jul 25, 2008·American Journal of Physiology. Cell Physiology·Siying YeBruce A Stanton
Nov 8, 2011·Fluids and Barriers of the CNS·Richard F Keep, David E Smith
Mar 4, 2003·Biological & Pharmaceutical Bulletin·Maria DaoudakiTheresia Thalhammer
Oct 29, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Isa CavacoVera Ribeiro
Jul 12, 2005·Pharmacogenomics·Chin-Chuan HungHorng-Huei Liou
Jul 11, 2001·Pharmacotherapy·C J MathenyG M Pollack
Aug 29, 2012·American Journal of Veterinary Research·Krystyna L OrzechowskiHaile F Yancy
Oct 20, 2010·International Journal of Molecular Sciences·Shengnan HeYuyang Jiang
Oct 11, 2007·Pharmacogenomics·Chin-Chuan HungHorng-Huei Liou
Jan 8, 2014·The Journal of Experimental Medicine·Radha RameshMark S Sundrud
Nov 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·R V KondratovA V Gudkov
Jul 30, 2002·Proceedings of the National Academy of Sciences of the United States of America·Alexia GarriguesStephane Orlowski
Jun 19, 2012·Annual Review of Microbiology·Rajendra Prasad, Andre Goffeau
May 15, 2002·Pharmacology & Toxicology·Gert Fricker, David S Miller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.